Biotage AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
90,769.00
100,045.00
134,885.00
128,622.00
174,263.00
177
Total Accounts Receivable
90,507.00
97,837.00
117,478.00
130,890.00
135,630.00
174
Inventories
85,887.00
108,379.00
97,182.00
88,906.00
95,794.00
132
Other Current Assets
7,352.00
8,775.00
7,059.00
7,561.00
3,565.00
11
Total Current Assets
274,515.00
315,036.00
356,604.00
355,979.00
409,252.00
494
Net Property, Plant & Equipment
41,608.00
43,057.00
44,719.00
45,447.00
45,303.00
49
Total Investments and Advances
530.00
78.00
-
18,645.00
17,838.00
17
Long-Term Note Receivable
694.00
730.00
690.00
1,156.00
-
2
Intangible Assets
229,986.00
215,345.00
219,191.00
220,038.00
222,669.00
379
Other Assets
-
-
2.00
1,587.00
1,404.00
-
Total Assets
592,247.00
619,010.00
668,832.00
695,196.00
757,201.00
1,003
ST Debt & Current Portion LT Debt
444.00
502.00
-
-
-
Accounts Payable
31,609.00
33,910.00
32,936.00
38,133.00
47,457.00
Income Tax Payable
1,307.00
848.00
2,317.00
1,085.00
1,899.00
Other Current Liabilities
54,589.00
67,656.00
82,431.00
88,503.00
95,021.00
Total Current Liabilities
87,949.00
102,916.00
117,684.00
127,721.00
144,377.00
Long-Term Debt
5,293.00
4,537.00
-
-
-
Provision for Risks & Charges
1,202.00
1,369.00
1,468.00
1,663.00
1,936.00
Deferred Taxes
43,079.00
42,299.00
45,678.00
50,585.00
59,114.00
Other Liabilities
19,194.00
5,073.00
1,075.00
815.00
656.00
Total Liabilities
115,473.00
116,360.00
122,175.00
131,958.00
148,590.00
Common Equity (Total)
476,774.00
502,650.00
546,657.00
563,238.00
608,611.00
Total Shareholders' Equity
476,774.00
502,650.00
546,657.00
563,238.00
608,611.00
Total Equity
476,774.00
502,650.00
546,657.00
563,238.00
608,611.00
Liabilities & Shareholders' Equity
592,247.00
619,010.00
668,832.00
695,196.00
757,201.00

About Biotage AB

View Profile
Address
Vimpelgatan 5
Uppsala UP 753 18
Sweden
Employees -
Website http://www.biotage.com
Updated 07/08/2019
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products include equipment for chromatography and purification, organic synthesis, analytical sample preparation, evaporation and concentration, peptide synthesis, and custom projects. The company was founded by Pal Nyrén, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Björn Ekström in 1997 and is headquartered in Uppsala, Sweden.